These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31079850)

  • 1. Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma.
    Koh YW; Han JH; Jeong D; Kim CJ
    Pathol Res Pract; 2019 Jul; 215(7):152444. PubMed ID: 31079850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
    Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
    PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Prognostic Significance of the Epithelial-Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score-Matched Analysis.
    Matsubara T; Tagawa T; Takada K; Toyokawa G; Shimokawa M; Kozuma Y; Akamine T; Haro A; Osoegawa A; Mori M
    Clin Lung Cancer; 2019 Jul; 20(4):e504-e513. PubMed ID: 31103348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of EDIL3 Expression and Correlation with Mesenchymal Phenotype and Microvessel Density in Lung Adenocarcinoma.
    Jeong D; Ban S; Oh S; Jin Lee S; Yong Park S; Koh YW
    Sci Rep; 2017 Aug; 7(1):8649. PubMed ID: 28819306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
    Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
    Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
    Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
    Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
    Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
    World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of epithelial-mesenchymal transition-related molecules in lung adenocarcinoma.
    Zhang Y; Wang LF; Gao JH; Li L; Jiang P; Lv X; Yu LX; Yang J; Li RT; Liu BR
    Curr Oncol; 2019 Apr; 26(2):e121-e127. PubMed ID: 31043817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma.
    Shi Y; Wu H; Zhang M; Ding L; Meng F; Fan X
    Diagn Pathol; 2013 May; 8():89. PubMed ID: 23706092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition.
    Ibrahim R; Matsubara D; Osman W; Morikawa T; Goto A; Morita S; Ishikawa S; Aburatani H; Takai D; Nakajima J; Fukayama M; Niki T; Murakami Y
    Hum Pathol; 2014 Jul; 45(7):1397-405. PubMed ID: 24775604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-induced transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential for progression of non-small cell lung cancer.
    Yang YG; Koh YW; Sari IN; Jun N; Lee S; Phi LTH; Kim KS; Wijaya YT; Lee SH; Baek MJ; Jeong D; Kwon HY
    Int J Cancer; 2019 Apr; 144(8):2020-2032. PubMed ID: 30318841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.
    Luo W; Fang W; Li S; Yao K
    Int J Cancer; 2012 Oct; 131(8):1863-73. PubMed ID: 22307379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of microscopic vessel invasion and visceral pleural invasion and their correlations with epithelial-mesenchymal transition, cancer stemness, and treatment failure in lung adenocarcinoma.
    Neri S; Menju T; Sowa T; Yutaka Y; Nakajima D; Hamaji M; Ohsumi A; Chen-Yoshikawa TF; Sato T; Sonobe M; Yoshizawa A; Haga H; Date H
    Lung Cancer; 2019 Feb; 128():13-19. PubMed ID: 30642445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung.
    Kim SH; Kim JM; Shin MH; Kim CW; Huang SM; Kang DW; Suh KS; Yi ES; Kim KH
    Histol Histopathol; 2012 May; 27(5):581-91. PubMed ID: 22419022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma.
    Zhang Y; Sun L; Gao X; Guo A; Diao Y; Zhao Y
    BMC Cancer; 2019 Jul; 19(1):670. PubMed ID: 31286874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma.
    Sowa T; Menju T; Sonobe M; Nakanishi T; Shikuma K; Imamura N; Motoyama H; Hijiya K; Aoyama A; Chen F; Sato T; Kobayashi M; Yoshizawa A; Haga H; Sozu T; Date H
    Cancer Med; 2015 Dec; 4(12):1853-62. PubMed ID: 26471868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma.
    Fan CC; Cheng WC; Huang YC; Sher YP; Liou NJ; Chien YC; Lin PS; Lin PS; Chen CH; Chang WC
    Sci Rep; 2017 Nov; 7(1):14617. PubMed ID: 29097801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-mesenchymal Transition (EMT) is Correlated with Patient's Prognosis of Lung Squamous Cell Carcinoma.
    Aruga N; Kijima H; Masuda R; Onozawa H; Yoshizawa T; Tanaka M; Inokuchi S; Iwazaki M
    Tokai J Exp Clin Med; 2018 Apr; 43(1):5-13. PubMed ID: 29637533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
    Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
    Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of PD-L1, cancer stem cell and epithelial-mesenchymal transition phenotype in non-small cell lung cancer.
    Koh YW; Han JH; Haam S
    Pathology; 2021 Feb; 53(2):239-246. PubMed ID: 33036771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.